多形膜蛋白A疫苗接种减少鼠衣原体诱导的生殖道病理
研究使用鼠衣原体生殖道感染模型,发现超过70%感染小鼠出现子宫扩张和/或输卵管积水,感染后10至15天出现脾肿大。以多形膜蛋白A联合CpG-ODN 1826佐剂接种可降低衣原体负荷并减少生殖道病变的发生率和严重程度,但单独佐剂加卵清蛋白对照组显著增加病变严重程度。
要点
- 超过70%的鼠衣原体感染小鼠出现子宫扩张和/或输卵管积水。
- PmpA加CpG-ODN 1826疫苗降低衣原体负荷,感染后第10天差异显著。
- PmpA加CpG-ODN 1826疫苗降低生殖道病变发生率和严重程度。
核心结论
- 重组PmpA加CpG-ODN 1826疫苗接种显著减少鼠衣原体诱导的组织损伤,但无保护性抗原时CpG-ODN 1826可能加重鼠衣原体诱导的组织损伤。
研究设计与样本
- 使用鼠衣原体生殖道感染模型进行疫苗接种研究,比较PmpA加CpG-ODN 1826与卵清蛋白加CpG-ODN 1826对照。
主要发现
- 超过70%的感染小鼠出现子宫扩张和/或输卵管积水。
- 感染后10至15天出现脾肿大。
- 可培养微生物在感染后前23天可检测到,生殖道病变最早于第15天出现,但许多病变在无可培养细菌时后期出现。
- 感染后43天生殖道中IFNγ、TNF和IL-6几乎检测不到。
- PmpA加CpG-ODN 1826疫苗降低衣原体负荷,感染后第10天差异显著,但之后不显著。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Chlamydia trachomatis serovars D-K are one of the most frequent causes of sexually transmitted infections of the female genital tract, with possible complications such as hydrosalpinx, pelvic inflammatory disease, extra-uterine gravidity or infertility. We used the murine genital tract infection model with C. muridarum for vaccination studies and found that more than 70% of the infected mice suffered from uterus dilatations and/or hydrosalpinx. Systemic consequences of the vaginal infection were apparent by splenomegaly ten to fifteen days post infection. While cultivable microorganisms were detectable for the first 23days post infection, the first lesions of the genital tract developed at day 15, however, many lesions occurred later in the absence of cultivable bacteria. Lesions were not accompanied by pro-inflammatory cytokines such as IFNɣ, TNF and IL-6, since these cytokines were almost undetectable in the genital tract 43days post infection. To prevent genital tract lesions, we vaccinated mice with the polymorphic membrane protein (Pmp) A in combination with CpG-ODN 1826 as adjuvant. The vaccine lowered the chlamydial burden and the differences were significant at day 10 post infection but not later. More importantly the vaccine decreased the rate and severity of genital tract lesions. Interestingly, control vaccination with the protein ovalbumin plus CpG-ODN 1826 enhanced significantly the severity but not the rate of pathologic lesions, which was presumably caused by the activation of innate immune responses by the adjuvant in the absence of a C. muridarum-specific adaptive immune response. In summary, vaccination with recombinant PmpA plus CpG-ODN 1826 significantly reduced C. muridarum-induced tissue damage, however, CpG-ODN 1826 may aggravate C. muridarum-induced tissue injuries in the absence of a protective antigen.
引用
- Müller T, Becker E, Stallmann S, et al. Vaccination with the polymorphic membrane protein A reduces Chlamydia muridarum induced genital tract pathology. Vaccine. 2017. PMID: 28413133. doi:10.1016/j.vaccine.2017.04.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。